Cavalier Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,137
Closed -$1.58M 85
2024
Q2
$1.58M Buy
11,137
+310
+3% +$35.7K 0.49% 48
2024
Q1
$1.21M Buy
10,827
+569
+6% +$67.8K 0.44% 53
2023
Q4
$1.33M Buy
10,258
+240
+2% +$33.1K 0.49% 52
2023
Q3
$1.63M Buy
10,018
+349
+4% +$61.4K 0.64% 46
2023
Q2
$1.77M Buy
+9,669
New +$1.39M 0.65% 42
2018
Q2
Sell
-63,300
Closed -$1.56M 148
2018
Q1
$1.56M Buy
63,300
+26,000
+70% +$683K 0.55% 40
2017
Q4
$1.07M Hold
37,300
0.43% 53
2017
Q3
$1.02M Buy
+37,300
New +$826K 0.49% 51

Other funds holding ACLS

Cavalier Investments's ACLS Position: Q3 2024 in Review

Cavalier Investments sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 11,137 shares — an estimated $1.58M sold.

Cavalier Investments first reported a position in ACLS in Q3 2017 and held it in 8 quarters. The position peaked at $1.77M in Q2 2023. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Cavalier Investments reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Cavalier Investments sold 11,137 Axcelis shares in Q3 2024, an estimated $1.58M.
  • Cavalier Investments first reported a position in Axcelis in Q3 2017 and held it in 8 quarters.
  • Cavalier Investments's Axcelis position peaked at $1.77M in Q2 2023.
  • 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Cavalier Investments's 13F filing for Q3 2024, filed 24 Oct 2024.